Background Fistulising perianal Crohn’s disease (CD) remains a debilitating condition, with few randomised controlled trials ...

Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for venous and lymphatic disease, ...

Vesalio, a global leader in vascular intervention, announced that results from the randomized NATURE clinical trial evaluating the enVast™ Coronary Thrombectomy System will be presented in a ...

A randomized controlled trial in Singapore found that, compared with offering clinician sampling alone, offering self-sampling or clinician sampling increased both high-risk HPV detection (3.1% vs. 0.

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, ...

DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures ...

Among patients with atrial fibrillation and predominantly chronic coronary syndrome undergoing PCI with intravascular imaging ...

Medically tailored groceries (MTG) lowered hemoglobin A1c (HbA1c) and improved food and nutrition security among Medicaid ...

Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C <50 mg/dL. Intervention uptake increased intensive and combination ...

A scientific shift could reshape thinking about Alzheimer’s disease—from a condition that is treated after symptoms emerge to ...

OKYO Pharma Limited has filed its annual report on Form 20-F for the fiscal year ended March 31, 2026, with the US Securities ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.